Ghazi Sharkas

Dr. Ghazi Sharkas

Ministry of Health, Amman, Al ‘Āşimah, Jordan
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2017 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
Ghazi SharkasGhazi Sharkas
Ghazi Sharkas
KAKamal H. Arqoub
Kamal H. Arqoub
Yousef KhaderYousef Khader
Yousef Khader
MTMohammad R. Tarawneh
Mohammad R. Tarawneh
ONOmar Nimri
Omar Nimri
HSHadil S. Subih
Hadil S. Subih
Objectives. To estimate the survival rate of colorectal cancer (CRC) and determine its predictors among Jordanian patients who were diagnosed in the period of 2005–2010. Methods. This study was based on Jordan cancer registry. All CRC cases that were registered in cancer registry during 2005–2010 were analyzed using the survival analysis. The last date for follow-up was 1st Oct 2016. Results. A total of 3005 patients with CRC were registered during 2005–2010. The overall 5-year and 10-year survival rates for patients with CRC were 58.2% and 51.8%, respectively. The 5-year survival rate decreased significantly from 60.4% for the age <50 years to 49.3% for the age ≥70 years (p<0.005). The 5-year survival rate was 72.1% for the localized stage, 53.8% for the regional stage, and 22.6% for the distant metastasis. In the multivariate analysis, the only factors that were significantly associated with survival were age, grade, stage, and location of tumor. Conclusions. The overall 5-year and ten-year survival rates for CRC were 58.2% and 51.8%, respectively. Increased age, poor differentiation, advanced cancer stage, and right-sided cancers were associated with lower survival rates. Screening strategies are needed for early detection of colon adenomas and colorectal cancer in Jordan.

17 October 2018 in Journal of Cancer Epidemiology
Verified
Journal Article
Open access
PDF file
Yousef KhaderYousef Khader
Yousef Khader
Ghazi SharkasGhazi Sharkas
Ghazi Sharkas
KAKamal H. Arkoub
Kamal H. Arkoub
MAMahmoud Alfaqih
Mahmoud Alfaqih
ONOmar Nimri
Omar Nimri
AKAlbaraa M. Khader
Albaraa M. Khader
Objectives. This study aimed to determine the overall incidence, trend, and epidemiology of cancer among Jordanians from 2000 to 2013 using data extracted from Jordan’s Cancer Registry (JCR). Methods. All cancer cases among Jordanians registered between 2000 and 2013 were analyzed using CanReg software and SPSS. The overall crude incidence rates (CIRs) and the age standardized rates (ASRs) of cancer per 100,000 were calculated. Results. A total of 58788 cancer cases were registered during the period 2000-2013. Of those, 28545 (48.6%) were males and 30243 (51.4%) were females. About three-quarters (77.3%) of the registered patients were ≥ 40 years in age. Overall, the average crude cancer incidence rate was 82.8/100,000 population during the 14-year study period. On the other hand, the ASR was 126/100,000 during the same period (124.2 /100,000 for males and 128.4 /100,000 for females). The cumulative top cancers among males were colorectal, lung, lymphoma, urinary bladder, and prostate, respectively, while those among females were breast, colorectal, lymphoma, thyroid, and uterine. The number of cancer cases has increased from 3370 in 2000 to 5409 in 2013 (60.5% increase over the 14 years). The percentage of increase was 68.4% in females and 52.5% in males. The ASR has also increased from 113.6 per 100,000 in 2000 to 142.1 per 100.000 in 2013 with a 25.1% of increase during the 14 years. Conclusion. Over the 14-year study period, incidence of cancer in Jordan has increased. However, it remains lower than that in other Eastern Mediterranean and Western countries. We recommend initiating screening programs for the most common types of cancer in Jordan that have valid screening tests to detect cancer during its early stages and reduce overall morbidity and mortality.

1 December 2021 in One Health
Verified
Journal Article
Open access
Saverio BellizziSaverio Bellizzi
Saverio Bellizzi
LAlora Shabib alsawalha
lora Shabib alsawalha
SASami Sheikh Ali
Sami Sheikh Ali
Ghazi SharkasGhazi Sharkas
Ghazi Sharkas
NMNazeema Muthu
Nazeema Muthu
NONathir Obeidat
Nathir Obeidat
The evolution of the COVID-19 pandemic in Jordan during the first 10 months of the epidemic was peculiar and can be easily categorized in three different phases: a first period featuring a very low number of reported cases, a second period with exponential growth from August with up to 8000 cases on the 18th November 2020, and a third phase with steady and progressive decline of the epidemiological curve. With the aim of better determine the entity of the population exposed to SARS-CoV-2, the Jordan Ministry of Health with the support of the WHO launched three rounds of the nationwide sero-prevalence survey. Using population proportionate to size (PPS) methodology, around 5000 individuals were selected from all Jordan governorates. Blood samples were collected from all participants and ELISA assays for total IgM, IgG antibodies to COVID-19 were used for testing at the National Public Health Laboratory. Results revealed that seroprevalence dramatically increased over time, with only a tiny fraction of seropositive individuals in August (0.3%), to increase up to more than 20-fold in October (7.0%) and to reach one-third of the overall population exposed by the end of 2020 (34.2%). While non age-specific trends were detected in infection rates across different age categories, in all three rounds of the seroprevalence study two out of three positive participants did not report any sign and/or symptom compatible with COVID-19. The serial cross-sectional surveys experience in Jordan allowed to gain additional insights of the epidemic over time in combination with context-specific aspects like adherence to public health and social measures (PHSM). On the other hand, such findings would be helpful for planning of public health mitigation measures like vaccinations and tailored restriction policies.

1 May 2019 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
HYH. Yusuf
H. Yusuf
HSH.S. Subih
H.S. Subih
BOBelal Obeidat
Belal Obeidat
Ghazi SharkasGhazi Sharkas
Ghazi Sharkas

1 November 2018 in Nutrition Research
Verified
Journal Article
Closed access
HShadil subih
hadil subih
ZZZainab Zueter
Zainab Zueter
BOBayan M. Obeidat
Bayan M. Obeidat
MAMohammad A. Al-Qudah
Mohammad A. Al-Qudah
SJSana'A Janakat
Sana'A Janakat
HBHiba A. Bawadi
Hiba A. Bawadi

11 March 2022 in Children
Verified
Journal Article
Open access
PDF file
SDSAFWAN Yousef DABABNEH
SAFWAN Yousef DABABNEH
MAmohammed Alsbou
mohammed Alsbou
NTNashat Taani
Nashat Taani
Ghazi SharkasGhazi Sharkas
Ghazi Sharkas
RIRefqi Ismael
Refqi Ismael
AAArab Almasri
Arab Almasri
Background: Phenylketonuria (PKU) is the most frequent inborn error in amino acid metabolism caused by a deficiency of the phenylalanine hydroxylase enzyme (PAH). If PKU is left untreated, high concentrations of phenylalanine (Phe) accumulate in the blood, leading to severe brain dysfunction, neurodevelopmental, behavioral and psychological problems. Data concerning the epidemiology of PKU in Jordan are limited. The main objectives of our study were to determine the prevalence of PKU in Jordan, analyze the PKU phenotypes, and identify major challenges in providing dietary management to PKU patients. Methods: Data were collected utilizing the medical records of PKU patients attending the PKU clinic at the Ministry of Health in Amman, Jordan, between 2008 and 2021. Results: The total number of patients diagnosed with PKU was 294. The prevalence of PKU was estimated to be 1/5263. Most patients were Jordanians (90.8%), and 9.2% were non-Jordanians. More than half of the patients (56%) were diagnosed through the national newborn screening (NBS) program. Regarding the phenotypes of PKU, 46.6% had moderate PKU, whereas 42.9% had the classic type of PKU and only 8 (2.7%) had cofactor Tetrahydrobiopterin (BH4) deficiency (atypical PKU). According to the age of diagnosis, 66% of patients were diagnosed more than 30 days post-birth. Consanguinity was found in 87.4% of patients, and the majority of patients, 218 (74.2%), had first-degree consanguinity. The most common complication was mental retardation (31%). Most patients were committed to dietary management (83%) and developed fewer complications. Conclusion: In our study, we demonstrated the importance of the NBS program in the early identification and diagnosis of new PKU cases which allows the initiation of treatment and dietary management to prevent severe complications of PKU in Jordan.